To build that understanding, as part one of the Your Cancer Is Our Challenge program, GSK sponsored a survey of more than 800 adults with gynecological cancers—including endometrial, ovarian ...
GSK’s Withdrawn Blood Cancer Drug Paves Path Back to Market Blenrep reduced risk of death in trial, said British drugmaker GSK predicts annual sales of over £3 billion if approved ...
We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. GSK hailed progress for its withdrawn blood cancer drug Blenrep on Thursday, raising the prospect of ...
GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...
GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...
Love crossword puzzles but don’t have all day to sit and solve a full-sized puzzle in your daily newspaper? That’s what The Mini is for! A bite-sized version of the New York Times’ well ...
Teva Pharmaceutical Industries Ltd. ADR-1.50% $19.72B ...
(Perhaps I should mention at this point that I hold shares in GlaxoSmithKline - one of three vaccine manufacturers - as part of a pension plan. They were bought as Glaxo shares before its merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback